Background: Gallstone disease (GD) belongs to the most frequent disorders in gastroenterology and causes high costs in our health-care systems. Gallstones are uncommon in children but frequent in adults, in particular in women, and are triggered by exogenous risk factors. Here, we summarize the current knowledge concerning the contribution of inherited predisposition to gallstone risk. Design: In this review, we present the current data and recent research on the genetics of gallstone disease. Results: Several GD-predisposing gene variants have been reported, with most prominent effects being conferred by a common variant (p.D19H) of the hepatic and intestinal cholesterol transporter ABCG5/G8. A smaller group of patients might develop gallstones primarily due low phosphatidylcholine concentrations in bile as a result of loss-of-function mutations of the ABCB4 transporter (low phospholipid-associated cholelithiasis syndrome). Regardless of the origin, the risk factors for gallstones lead to the supersaturation of bile with insoluble compounds, in particular cholesterol. As result, cholesterol stones develop and present the most frequent type of gallstones. Laparoscopic cholecystectomy with low morbidity and mortality is currently the most common and effective method for the therapy of symptomatic gallbladder stones. Conclusions: Gallstone disease represents a multifactorial condition and previous studies have identified the major genetic contributors to gallstone formation. The increasing knowledge about the pathomechanisms of hepatobiliary metabolism and GD as well as the identification of additional risk factors might help to overcome the current invasive therapy by specific lifestyle intervention and precise molecular treatment.
| INTRODUCTION
Gallstone disease (GD) is frequent. Up to 20% of all Europeans have gallstones. Gallstones develop and grow inside the gallbladder or, less frequently, in the bile ducts. Based on their chemical composition, gallstones are classified into cholesterol, black or brown bilirubin stones (pigment stones). Cholesterol and black pigment stones are formed in the gallbladder, whereas brown pigment stones grow in obstructed and infected bile ducts. 1 More than 80% of the biliary stones consist of cholesterol and represent a defect of biliary cholesterol homeostasis. Most gallstones are silent. On the other hand, every fifth carrier of gallstones develops symptomatic GD. In case of symptomatic gallbladder stones, the surgical removal of gallbladder, that is cholecystectomy, is recommended. Non-surgical approaches, such as litholysis with ursodeoxycholic acid or extracorporeal shock wave lithotripsy, have become less relevant and are not recommended, however might be considered in selected groups of patients. 2 The rates of cholecystectomy vary: Lower annual rates are reported in Scandinavia (65 per 100 000 inhabitants), while in Germany and the United States cholecystectomies are performed more frequently (200 per 100 000 inhabitants). In countries with extraordinary prevalence of gallstones, for example Chile, the cholecystectomy rate exceeds 220 per 100 000 inhabitants. 3 These differences are most likely not solely caused by the prevalence of GD but might as well be the result of different medical approaches to patients with symptomatic and mildly-symptomatic stones. Primary gallbladder stones can cause acute cholecystitis but may also migrate into and occlude the common bile duct (secondary stones). Additional common and potentially life-threatening complications of bile duct stones are acute cholangitis and biliary pancreatitis.
In this manuscript, we will present an update of the current knowledge concerning the exogenous and genetic risk factors of gallstones. We focus on the pathobiological background of the disease in humans and conclude with briefly addressing future directions of research in cholelithiasis.
| PATHOBIOLOGY
Currently, three main pathophysiological mechanisms have been identified to be responsible for the crystallization of cholesterol in bile. These include the supersaturation of bile with cholesterol, gallbladder hypomotility and the destabilization of bile by proteins or pathogens. Among these, cholesterol supersaturation of bile remains the most critical determinant of GD. Hydrophobic sterol molecules are secreted into bile via the ATP-dependent hemitransporters ABCG5 and ABCG8, which are localised in the hepatocanalicular membrane of the hepatocyte. 4 In hepatic bile, cholesterol is solubilised in mixed micelles and vesicles, which are composed of bile acids and phosphatidylcholine. 5 These biliary lipids enter bile via the bile salt export pump ABCB11 and the phosphatidylcholine translocator ABCB4, respectively. 4 If biliary cholesterol concentration increases or bile salt and/or phosphatidylcholine concentrations drop, cholesterol can no longer be fully taken up by mixed micelles. In supersaturated bile, unstable vesicles ("liquid crystals") develop, which are enriched with cholesterol. These cholesterol-rich vesicles aggregate and fuse into multilamellar vesicles, from which solid cholesterol monohydrate crystals precipitate. Gallbladder hypomotility also contributes to stone formation. Gallbladder hypomotility might be caused, for example, by increased progesterone levels (for example during pregnancy), profound weight loss, or total parenteral nutrition. Excess cholesterol accumulates in the smooth muscle cells of the gallbladder wall and leads to stiffening of cell membranes and decoupling of G protein-mediated signal transduction, resulting in impaired gallbladder contraction. 6 This prolongs the residence time of bile in the gallbladder, which results in nucleation, precipitation, aggregation and growth of cholesterol crystals. The nucleation and growth of the bile stones are further modulated by biliary promoter (alfa 1-acid glycoprotein, aminopeptidase N, immunoglobulins G and M, phospholipase C) and inhibitor proteins (apolipoprotein A, immunoglobulin A), which interact with vesicles and crystals. 1 The rare black pigment stones are often a consequence of chronic haemolysis, resulting in increased bilirubin concentrations in bile. 7 Furthermore, bile salt loss due to ileal resection, Crohn disease or liver cirrhosis increases colonic absorption, enterohepatic circulation and biliary concentration of bilirubin. In infected bile, conjugated bilirubin is hydrolysed by bacterial b-glucuronidases.
| EXOGENOUS RISK FACTORS
Present findings point to a multifactorial genesis of gallbladder stones. 8 Moreover, the incidence of gallstones in developing societies, previously not exceeding 5%, has steadily increased in the last decades, 9 which is attributed to, among others, the shift in dietary patterns also known as "Westernized" or lithogenic diets. 10 Nutrition studies indicate that increased energy intake with high caloric and carbohydrate-rich diets, high fructose intake, low fibre contents as well as the consumption of fast food and low vitamin C levels increase the risk of gallstone formation.
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Alike in the case of atherosclerosis, the risk of GD increases with overweight and obesity, diabetes mellitus, insulin resistance, diabetes and dyslipidemia, in particular, hypertriglyceridemia and low high-density lipoprotein cholesterol concentrations. Hence, gallstones have been considered a "fellow traveler" of the metabolic syndrome for a long time. 12 Hyperinsulinemia is associated with increased hepatic cholesterol uptake and secretion as well as hyposecretion of bile salts. 13 Low fibre diet prolongs intestinal transit times and thereby increases the synthesis of the lithogenic hydrophobilic bile acid deoxycholic acid by intestinal bacteria that belong to the genus Clostridium.
14 Large prospective studies have quantified the risks associated with exogenous risk factors, as summarised in Table 1 . As the effects of these risk factors accumulate over time, it implies-together with age-dependent alterations of cholesterol homeostasis, bile secretion and gallbladder motility -that the prevalence of stones increases with age. For example, in Germany, the maximum prevalence rate of gallstones of 57% was observed in women between 70 and 80 years of age, as documented by abdominal ultrasound. 15 
| TWIN STUDIES
Large twin studies have allowed the systematic analysis of exogenous and genetic risk factors for gallstones. Conclusive evidence for the role of genetic factors in humans was provided for the first time by a large-scale study combining the Swedish Twin Registry with the inpatient-discharge and causes-of-death registries for symptomatic GD and gallstone surgery-related diagnoses in 43 141 twin pairs born between 1900 and 1958. 16 There was a significantly higher correlation between phenotypic variation in monozygotic than dizygotic twins (12% vs 6%). However, the rather low correlation among monozygotic twins indicates that environmental factors are also relevant for GD. Final risk estimates were estimated by structural equation modelling. This analysis of variance and correlations models genotypic and environmental effects as the contribution of unmeasured (latent) variables to the multivariate phenotypic differences. As Figure 1 illustrates, genetic factors accounted for about 25% (95% confidence interval (CI) = 9%-40%), shared environmental effects (eg diet in childhood) for 13% (95% CI = 1%-25%) and individual environmental effects for 62% (95% CI = 56%-68%) of the phenotypic variation among twins.
| GENETIC RISK FACTORS

| Common genetic risk factors associated with gallstone disease
Associations between multiple lithogenic (ie promoting the formation of stones in an organic body) gene variants and gallstone formation have been observed, indicating that cholelithiasis is a polygenic complex disease. Quantitative trait locus analysis in inbred strains of mice challenged with lithogenic diets containing high concentrations of cholesterol (and cholic acid) led to the detection of many lithogenic genes to date, including the hepatobiliary cholesterol transporter Abcg5/g8. 3 The disease susceptibility loci were mapped by identifying the genomic regions where the distributions of marker genotypes correlate with differences in stone phenotypes in experimental crosses of inbred mouse strains. Female gender is a well-known genetic risk factor in humans: Women are more likely to develop gallstones than men. This difference might, at least in part, be caused by the increased incidence of gallstones in pregnancy (5%). Estrogens induce hepatic cholesterol synthesis and secretion, and progesterone causes gallbladder hypomotility. 3 Genome-wide association study (GWAS) in humans identified a single variant of the hepatobiliary cholesterol transporter ABCG8 (p.D19H) as the most frequent genetic risk factor for GD in humans. 17 The mutation leads to the change in the base guanine to cytosine at position 55 (c.55G>C), which results in the substitution of the amino acid aspartic acid by histidine in the final transport protein (p.D19H). Approximately 5% of Europeans carry the p.D19H variant of the ABCG8 gene. Subsequent studies showed that, for example, obese women older than 60 years who are homozygous carriers of the p.D19H risk allele have a 13% absolute 10-year risk of symptomatic GD compared to 2%-4% in non-carriers in the same risk stratum. 18 To date, the genetic association has been replicated in numerous international cohorts (Table 2) , hence this genetic factor represents a common gallstone risk factor worldwide. 19 Functional in vitro studies 20 and measurements of phytosterol and cholesterol precursor concentrations indicate that individuals predisposed to GD are characterised by an increased biliary output of cholesterol in the setting of relatively low intestinal cholesterol absorption, pointing to enhanced whole-body sterol clearance (Figure 2 ). The comparison of serum sterols showed lower concentrations of F I G U R E 1 Pie chart summarising the results of the Swedish twin study. 16 The figure illustrates the contribution of genetic and environmental factors to gallstone disease. Structural equation modelling was employed to estimate the attributable fractions that explain the observed phenotypic variation phytosterols, which represent surrogate markers for intestinal cholesterol absorption, and higher levels of cholesterol precursors, reflecting cholesterol biosynthesis, in GD patients as compared to controls. 21 An ethnic gradient in the ratios of phytosterols to cholesterol precursors is also apparent (Germans > Hispanics > Amerindians), which correlates negatively with gallstone susceptibility. In a new follow-up study by Nissinen et al, 22 this issue has been examined further in a cohort of gallstone-free children, who developed gallstones in later life. The study analysed the serum surrogate markers of cholesterol metabolism in children and adolescents, who were recruited in 1980, and by the year of 2012, a total of 95 individuals had developed gallstones. Compared to 190 matched gallstone-free individuals from the same cohort, the study demonstrated that those who developed gallstones during follow-up had lower serum concentrations of plant sterols and cholestanol and higher ratios of cholesterol precursors to plant sterols in childhood; different in dietary habits or BMI were not apparent at this point. Thus, this finding supports the concept that the lithogenic phenotype is present early in life and that genetic predisposition can already be detected in childhood. 23 Together with the common Gilbert promoter variant of the UDP glucuronosyl transferase gene (UGT1A1), which appears to be an additional risk factor at least in men, risk genes confer about 15% of the population attributable gallstone risk. 24 The UGT1A1 variant might promote the formation of the bilirubin nidus of cholesterol gallstones.
A large meta-analysis of GWAS of 15,241 women with European ancestry, using the Human cardiovascular disease (HumanCVD) BeadChip containing~53 000 single nucleotide polymorphisms (SNPs), examined the association of gallbladder disease with approximately 2000 gene-centric loci involved in lipid metabolism and obesity pathways. The authors reported four independent SNP effects in ABCG5/G8 and also identified novel associations of the glucokinase regulatory protein (GCKR) SNP rs1260326 and the TTC39B SNP rs686030 with GD. 25 GCKR is known to be associated with diabetes and glycaemic traits, whereas TTC39B deficiency stabilizes LXR reducing both 
F I G U R E 2 Sterol transport and
synthesis in individuals at-risk for cholesterol gallstones. Based on phytosterols and cholesterol precursors as surrogate markers of cholesterol transport and synthesis, these individuals are characterised by an increased clearance/ excretion of cholesterol (and phytosterols). This primary event may be followed by a compensatory increase in cholesterol synthesis in liver and peripheral tissues. The critical phenotype, in particular the increased excretion of sterols into intestine and bile, is present in at-risk individuals already before gallstones develop. From 21 atherosclerosis and steatohepatitis. 26 Furthermore, another meta-analysis of GWAS 27 identified additional susceptibility loci for GD, all of which confer low additional risk (Table 3) . They include the rate-limiting enzyme of bile salt synthesis (cholesterol 7a-hydroxylase) and a sulfo-conjugation enzyme for bile salts (SULT21). In addition to these common variants, rare mutations in ABCB4, ABCB11, CFTR (cystic fibrosis transmembrane conductance regulator, also known as ABCC7) or the CYP7A1 gene have been demonstrated to cause gallstones by altering bile secretion and composition. NPC1L1 (Niemann-Pick C1-Like 1) is responsible for intestinal and hepatobiliary cholesterol absorption. Functional studies showed that "loss-of-function" mutations of NPC1L1 are associated with lower intestinal cholesterol absorption and changes in plasma low-density lipoprotein (LDL) cholesterol levels. The same effect is achieved by ezetimibe, a drug targeting NPC1L1. A Danish study comprising 67 385 individuals from the general population demonstrated that NPC1L1 gene variants are associated with decreased concentrations of plasma LDL cholesterol, protecting against ischaemic vascular diseases, but a higher risk of symptomatic GD. 28 This association became even stronger when the NPC1L1 and ABCG8 variants were combined in a single genotype score. This supports the speculation that genetically reduced activity of NPC1L1 decreases the reuptake of cholesterol from bile and promotes biliary cholesterol supersaturation. A recent study from Wu et al 29 in a Chinese population found a significantly higher minor allele frequency of the p NPC1L1 polymorphism g.1679C>G (rs2072183) in symptomatic gallstone-carriers compared with stone-free controls. Moreover, this alteration was associated with lower hepatic NPC1L1 mRNA expression, increased biliary molar percentages of cholesterol and higher cholesterol saturation indexes.
| Low phospholipid-associated cholelithiasis (LPAC) syndrome
A specific subgroup of patients with gallstones present with low phospholipid-associated cholelithiasis (LPAC) syndrome. LPAC syndrome is defined by early-onset cholelithiasis (<40 years), concurrent gallbladder, bile duct and/or intrahepatic cholesterol gallstones, and recurrence of biliary symptoms after cholecystectomy. 30 LPAC syndrome is caused by mutations of the ABCB4 gene and is part of the phenotypic spectrum of ABCB4 deficiency, which also comprises severe cholestatic liver diseases in children. 4 Interestingly, a recent GWAS for GD in 8258 Icelandic patients, for whom discharge diagnoses were available from the Landsp ıtali University Hospital in Reykjav ık, revealed a significant association with ABCB4: The two ABCB4 mutations that were significantly associated with gallstones at the genome-wide level are the missense single nucleotide polymorphism p.G622E and the frameshift insertion p.L445GfsX22, which conferred odds ratios for gallstones of 2.7 and 3.1, respectively. 31 Interestingly in the Iceland population, ABCB4 variants were not only associated with gallstones and intrahepatic cholestasis of pregnancy but with liver cirrhosis and cancer. 31 Last but not least, a GWAS of 1042 Indian patients with gallbladder cancer and 1709 controls identified significant associations between four SNPs in the chromosomal region harbouring ABCB4 (and ABCA1), pointing to a potential mechanistic link between gallstone and gallbladder cancer risk. These findings might explain to a certain extent the effects of genetic variants of hepatobiliary transporters on the development of gallbladder cancer.
T A B L E 3 Genetic polymorphisms associated with gallstone disease in GWAS
Gene locus Variants Cases (N) Population
Odds ratio 95% CI P-value References 6 | CONCLUSIONS As delineated above, recent studies have led to the identification of common and rare genetic variants that increase the odds of developing gallstones. Now, mechanistic studies are needed to clarify the functional mechanisms of these variants. Most of all, the effects of the ABCG8 p.19H variant should be investigated in detail. Analyses of other prolithogenic mutations are also warranted. This will not only improve our understanding of the pathogenesis of stone formation but might also enable the development of preventive strategies, including novel compounds, which might be tailored for individuals carrying gallstone-triggering factors and gene variants.
